Capital Ii Llc Orbimed, Director at AVANIR PHARMACEUTICALS (AVN), sold 629,121 shares at $9.79 ($6.2M) on 2006-05-31, disclosed to the SEC on 2006-06-02.
Open-market sale of $6.2M AVN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.